Arena Pharmaceuticals, Inc. (ARNA) financial statements (2022 and earlier)

Company profile

Business Address 6154 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including: 1,10474044627191
Cash and cash equivalents 22024316115991
Short-term investments 88449628588 
Other undisclosed cash, cash equivalents, and short-term investments    24 
Receivables  25220
Inventory, net of allowances, customer advances and progress billings     7
Inventory     7
Contract with customer, asset   1
Disposal group, including discontinued operation    17 
Other undisclosed current assets 35199(10)2
Total current assets: 1,139760461281120
Noncurrent Assets
Property, plant and equipment 2225233044
Long-term investments and receivables  3718224 
Long-term investments  3718224 
Intangible assets, net (including goodwill)     2
Intangible assets, net (excluding goodwill)     2
Disposal group, including discontinued operation, noncurrent assets    1 
Other noncurrent assets 29181043
Deferred tax assets, net110  
Other undisclosed noncurrent assets    (1) 
Total noncurrent assets: 514142265849
TOTAL ASSETS: 1,1911,174687339169
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 352516812
Accounts payable 126626
Accrued liabilities 55111
Employee-related liabilities 1914955
Restructuring reserve     0
Estimated litigation liability    24 
Disposal group, including discontinued operation    28 
Deferred revenue and credits135
Other undisclosed current liabilities 2319141216
Total current liabilities: 5845307264
Noncurrent Liabilities
Liabilities, other than long-term debt 1112123
Deferred revenue and credits12
Other liabilities 1112111
Other undisclosed noncurrent liabilities 4146495862
Total noncurrent liabilities: 5258516065
Total liabilities: 11010381132129
Stockholders' equity
Stockholders' equity attributable to parent 1,0801,07160620740
Common stock 00000
Additional paid in capital 2,5872,1732,1071,6991,442
Accumulated other comprehensive income (loss) 11(0)(1)(3)
Accumulated deficit (1,508)(1,103)(1,501)(1,490)(1,399)
Stockholders' equity attributable to noncontrolling interest     0
Total stockholders' equity: 1,0801,07160620740
TOTAL LIABILITIES AND EQUITY: 1,1911,174687339169

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 08061821124
Cost of revenue  (14)(1)(0)(14)
Cost of goods and services sold     (9)
Gross profit: 07921721110
Operating expenses (427)(309)(162)(113)(127)
Operating income (loss): (427)483(145)(92)(17)
Nonoperating income (expense) 22256(4)(6)
Investment income, nonoperating 2427900
Other nonoperating income 23320
Interest and debt expense (5)(5)(6)(6)(7)
Other undisclosed income from continuing operations before equity method investments, income taxes     7
Income (loss) from continuing operations before equity method investments, income taxes: (409)503(145)(102)(23)
Other undisclosed income from continuing operations before income taxes 556  
Income (loss) from continuing operations before income taxes: (405)508(139)(102)(23)
Income tax expense (benefit)  (110)110  
Other undisclosed income from continuing operations    6 
Income (loss) from continuing operations: (405)398(29)(96)(23)
Income (loss) from discontinued operations   (1)3 
Income (loss) before gain (loss) on sale of properties: (405)398(29)(93)(23)
Other undisclosed net loss     (0)
Net income (loss): (405)398(29)(93)(23)
Net income attributable to noncontrolling interest    10
Net income (loss) available to common stockholders, diluted: (405)398(29)(91)(23)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss): (405)398(29)(93)(23)
Other comprehensive income (loss) (1)1(0)  
Other undisclosed comprehensive income (loss)  (0)02(2)
Comprehensive income (loss): (405)399(29)(91)(25)
Comprehensive income, net of tax, attributable to noncontrolling interest    10
Other undisclosed comprehensive income, net of tax, attributable to parent 0    
Comprehensive income (loss), net of tax, attributable to parent: (405)399(29)(90)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: